MétaCan
Menu
Back to cohort

P962: CHANGE IN SOLUBLE BCMA LEVEL MAY BE A SURROGATE MARKER OF EARLY RESPONSE TO THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM A PHASE I STUDY OF CEVOSTAMAB

2022· article· en· W4283714328 on OpenAlexaff
R. Nakamura, R. Hendricks, Romina Dokhaei, Monica Damayani Susilo, D. Wilson, S. Trudel, Aaron B. Cohen, S. J. Harrison, A. Krishnan, Rodrigo Fonseca, J. I. Adamkewicz, M. Li, C. Wong, J. Cooper, T. Sumiyoshi

Bibliographic record

VenueHemaSphere · 2022
Typearticle
Languageen
FieldMedicine
TopicMonoclonal and Polyclonal Antibodies Research
Canadian institutionsUniversity of TorontoPrincess Margaret Cancer Centre
Fundersnot available
KeywordsMedicineMultiple myelomaOncologyInternal medicineCytokine release syndromeBiomarkerRefractory (planetary science)Surrogate endpointGastroenterologyImmunologyImmunotherapyCancerBiology

Abstract

fetched live from OpenAlex

Background: Cevostamab is an FcRH5xCD3 bispecific antibody that facilitates T-cell directed killing of myeloma cells, and has shown promising activity and manageable safety in a Phase I study in patients (pts) with RRMM (NCT03275103; Trudel et al. ASH 2021). B-cell maturation antigen (BCMA) is a membrane-bound protein that is expressed preferentially by malignant plasma cells and has become an important therapeutic target in MM. Shedding of membrane-bound BCMA, mediated by γ-secretase, gives rise to the soluble form of BCMA (sBCMA) which is often present at elevated levels in pts with MM. Normalization of sBCMA may be a predictor of response to therapy, which may be independent of treatment and target. Aims: To evaluate sBCMA as a biomarker of early response in pts enrolled in the single step-up dosing cohorts of the cevostamab Phase I study. Methods: Plasma samples were collected at baseline and at Cycle (C) 1 Day (D) 1 (pre-infusion and end of infusion [EOI]), C1D2, C1D4, C1D8 (pre-infusion and EOI), C1D9, C1D11, and C2D1 (pre-infusion and EOI). sBCMA levels were quantified using hybrid immunoaffinity capture with LC-MS/MS. Pts were stratified by refractory status, prior therapy, prior transplant, cytogenetic risk and response (responder [≥PR] or non-responder [

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.071
GPT teacher head0.328
Teacher spread0.257 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueHemaSphereSame topicMonoclonal and Polyclonal Antibodies ResearchFrench-language works237,207